+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atopic Dermatitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 89 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5926389
Description Jump to:
Atopic dermatitis (AD) drugs, including corticosteroids, calcineurin inhibitors, PDE4 inhibitors, biologics, and others, address a chronic skin condition affecting 230 million people globally, with 20% of children and 10% of adults impacted. The market is driven by rising prevalence in urbanized areas, environmental factors like pollution, and an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050). Novel biologics like dupilumab (70% EASI-75 response) and JAK inhibitors improve efficacy, while 70 new compounds are in development. The global AD drugs market is estimated at USD 10.0-18.0 billion in 2025, with a CAGR of 7%-12% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high AD prevalence and biologic adoption, while Canada focuses on environmental triggers.
  • Europe: Germany, France, and the UK drive growth with advanced dermatology care.
  • Asia Pacific: China and Japan see rising cases due to urbanization, with India emphasizing affordable treatments.
  • Rest of the World: Brazil enhances dermatology infrastructure, while the Middle East addresses allergy-related AD.

Distribution Channel Analysis

  • Hospital Pharmacies: Expected growth of 7.5%-12.5%, driven by biologics for severe AD. Trends focus on specialized care.
  • Retail Pharmacies: Projected growth of 7.0%-12.0%, linked to topical treatments. Advances emphasize accessibility.
  • Other Pharmacies: Anticipated growth of 6.5%-11.5%, covering online platforms. Trends highlight digital prescriptions.

Type Analysis

  • Corticosteroids: Expected growth of 6.0%-11.0%, used for mild AD. Trends focus on low-potency formulations.
  • Calcineurin Inhibitors: Projected growth of 6.5%-11.5%, effective for sensitive areas. Developments prioritize safety profiles.
  • PDE4 Inhibitors: Anticipated growth of 7.0%-12.0%, for moderate AD. Trends highlight non-steroidal options.
  • Biologics: Expected growth of 8.0%-13.0%, offering high efficacy. Advances focus on IL-4/13 and IL-31 inhibitors.
  • Others: Projected growth of 6.8%-11.8%, covering JAK inhibitors. Trends emphasize oral therapies.

Key Market Players

  • Sanofi: Offers dupilumab for severe AD.
  • Pfizer: Develops JAK inhibitors for AD management.
  • Regeneron Pharmaceuticals: Co-develops dupilumab with Sanofi.
  • Eli Lilly: Provides novel biologics for skin conditions.
  • LEO Pharma: Focuses on topical AD treatments.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, as high R&D costs and regulatory hurdles exist, but unmet needs attract new players.
  • Threat of Substitutes: Moderate, with non-pharmacological therapies competing, but severe AD requires drugs.
  • Bargaining Power of Buyers: Moderate, as insurers negotiate prices, but novel biologics limit options.
  • Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
  • Competitive Rivalry: High, with companies competing on efficacy, safety, and innovation.

Market Opportunities and Challenges

Opportunities:

  • Addressing 230 million AD patients globally.
  • Targeting 20% of children and 10% of adults with AD.
  • Leveraging biologics, achieving 70% EASI-75 response.
  • Developing 70 new compounds in R&D.
  • Managing urban pollution-driven AD cases.
  • Supporting an aging population, projected at 2.1 billion by 2050.

Challenges:

  • High costs of biologics limiting access.
  • Regulatory delays for novel therapies.
  • Side effects of JAK inhibitors requiring monitoring.
  • Limited AD awareness in low-income regions.
  • Competition from non-pharmacological treatments.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Atopic Dermatitis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Atopic Dermatitis Drug Market in North America (2020-2030)
8.1 Atopic Dermatitis Drug Market Size
8.2 Atopic Dermatitis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Atopic Dermatitis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Atopic Dermatitis Drug Market in South America (2020-2030)
9.1 Atopic Dermatitis Drug Market Size
9.2 Atopic Dermatitis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Atopic Dermatitis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Atopic Dermatitis Drug Market in Asia & Pacific (2020-2030)
10.1 Atopic Dermatitis Drug Market Size
10.2 Atopic Dermatitis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Atopic Dermatitis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Atopic Dermatitis Drug Market in Europe (2020-2030)
11.1 Atopic Dermatitis Drug Market Size
11.2 Atopic Dermatitis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Atopic Dermatitis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Atopic Dermatitis Drug Market in MEA (2020-2030)
12.1 Atopic Dermatitis Drug Market Size
12.2 Atopic Dermatitis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Atopic Dermatitis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Atopic Dermatitis Drug Market (2020-2025)
13.1 Atopic Dermatitis Drug Market Size
13.2 Atopic Dermatitis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Atopic Dermatitis Drug Market Size by Type
Chapter 14 Global Atopic Dermatitis Drug Market Forecast (2025-2030)
14.1 Atopic Dermatitis Drug Market Size Forecast
14.2 Atopic Dermatitis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Atopic Dermatitis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Atopic Dermatitis Drug Information
15.1.3 SWOT Analysis of Sanofi
15.1.4 Sanofi Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Pfizer
15.2.1 Company Profile
15.2.2 Main Business and Atopic Dermatitis Drug Information
15.2.3 SWOT Analysis of Pfizer
15.2.4 Pfizer Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 AstraZeneca
15.3.1 Company Profile
15.3.2 Main Business and Atopic Dermatitis Drug Information
15.3.3 SWOT Analysis of AstraZeneca
15.3.4 AstraZeneca Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Novartis
15.4.1 Company Profile
15.4.2 Main Business and Atopic Dermatitis Drug Information
15.4.3 SWOT Analysis of Novartis
15.4.4 Novartis Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Eli Lilly
15.5.1 Company Profile
15.5.2 Main Business and Atopic Dermatitis Drug Information
15.5.3 SWOT Analysis of Eli Lilly
15.5.4 Eli Lilly Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 AbbVie
15.6.1 Company Profile
15.6.2 Main Business and Atopic Dermatitis Drug Information
15.6.3 SWOT Analysis of AbbVie
15.6.4 AbbVie Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Regeneron Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Atopic Dermatitis Drug Information
15.7.3 SWOT Analysis of Regeneron Pharmaceuticals
15.7.4 Regeneron Pharmaceuticals Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 LEO Pharma
15.8.1 Company Profile
15.8.2 Main Business and Atopic Dermatitis Drug Information
15.8.3 SWOT Analysis of LEO Pharma
15.8.4 LEO Pharma Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 GALDERMA LABORATORIES
15.9.1 Company Profile
15.9.2 Main Business and Atopic Dermatitis Drug Information
15.9.3 SWOT Analysis of GALDERMA LABORATORIES
15.9.4 GALDERMA LABORATORIES Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.10 Otsuka Pharmaceutical
15.10.1 Company Profile
15.10.2 Main Business and Atopic Dermatitis Drug Information
15.10.3 SWOT Analysis of Otsuka Pharmaceutical
15.10.4 Otsuka Pharmaceutical Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.11 Incyte Corporation
15.11.1 Company Profile
15.11.2 Main Business and Atopic Dermatitis Drug Information
15.11.3 SWOT Analysis of Incyte Corporation
15.11.4 Incyte Corporation Atopic Dermatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Atopic Dermatitis Drug Report
Table Data Sources of Atopic Dermatitis Drug Report
Table Major Assumptions of Atopic Dermatitis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Atopic Dermatitis Drug Picture
Table Atopic Dermatitis Drug Classification
Table Atopic Dermatitis Drug Applications
Table Drivers of Atopic Dermatitis Drug Market
Table Restraints of Atopic Dermatitis Drug Market
Table Opportunities of Atopic Dermatitis Drug Market
Table Threats of Atopic Dermatitis Drug Market
Table COVID-19 Impact For Atopic Dermatitis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Atopic Dermatitis Drug
Table Cost Structure Analysis of Atopic Dermatitis Drug
Table Key End Users
Table Latest News of Atopic Dermatitis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Atopic Dermatitis Drug Market
Table Policy of Atopic Dermatitis Drug Market
Table 2020-2030 North America Atopic Dermatitis Drug Market Size
Figure 2020-2030 North America Atopic Dermatitis Drug Market Size and CAGR
Table 2020-2030 North America Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 North America Atopic Dermatitis Drug Key Players Revenue
Table 2020-2025 North America Atopic Dermatitis Drug Key Players Market Share
Table 2020-2030 North America Atopic Dermatitis Drug Market Size by Type
Table 2020-2030 United States Atopic Dermatitis Drug Market Size
Table 2020-2030 Canada Atopic Dermatitis Drug Market Size
Table 2020-2030 Mexico Atopic Dermatitis Drug Market Size
Table 2020-2030 South America Atopic Dermatitis Drug Market Size
Figure 2020-2030 South America Atopic Dermatitis Drug Market Size and CAGR
Table 2020-2030 South America Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 South America Atopic Dermatitis Drug Key Players Revenue
Table 2020-2025 South America Atopic Dermatitis Drug Key Players Market Share
Table 2020-2030 South America Atopic Dermatitis Drug Market Size by Type
Table 2020-2030 Brazil Atopic Dermatitis Drug Market Size
Table 2020-2030 Argentina Atopic Dermatitis Drug Market Size
Table 2020-2030 Chile Atopic Dermatitis Drug Market Size
Table 2020-2030 Peru Atopic Dermatitis Drug Market Size
Table 2020-2030 Asia & Pacific Atopic Dermatitis Drug Market Size
Figure 2020-2030 Asia & Pacific Atopic Dermatitis Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 Asia & Pacific Atopic Dermatitis Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Atopic Dermatitis Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Atopic Dermatitis Drug Market Size by Type
Table 2020-2030 China Atopic Dermatitis Drug Market Size
Table 2020-2030 India Atopic Dermatitis Drug Market Size
Table 2020-2030 Japan Atopic Dermatitis Drug Market Size
Table 2020-2030 South Korea Atopic Dermatitis Drug Market Size
Table 2020-2030 Southeast Asia Atopic Dermatitis Drug Market Size
Table 2020-2030 Australia Atopic Dermatitis Drug Market Size
Table 2020-2030 Europe Atopic Dermatitis Drug Market Size
Figure 2020-2030 Europe Atopic Dermatitis Drug Market Size and CAGR
Table 2020-2030 Europe Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 Europe Atopic Dermatitis Drug Key Players Revenue
Table 2020-2025 Europe Atopic Dermatitis Drug Key Players Market Share
Table 2020-2030 Europe Atopic Dermatitis Drug Market Size by Type
Table 2020-2030 Germany Atopic Dermatitis Drug Market Size
Table 2020-2030 France Atopic Dermatitis Drug Market Size
Table 2020-2030 United Kingdom Atopic Dermatitis Drug Market Size
Table 2020-2030 Italy Atopic Dermatitis Drug Market Size
Table 2020-2030 Spain Atopic Dermatitis Drug Market Size
Table 2020-2030 Belgium Atopic Dermatitis Drug Market Size
Table 2020-2030 Netherlands Atopic Dermatitis Drug Market Size
Table 2020-2030 Austria Atopic Dermatitis Drug Market Size
Table 2020-2030 Poland Atopic Dermatitis Drug Market Size
Table 2020-2030 Russia Atopic Dermatitis Drug Market Size
Table 2020-2030 MEA Atopic Dermatitis Drug Market Size
Figure 2020-2030 MEA Atopic Dermatitis Drug Market Size and CAGR
Table 2020-2030 MEA Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 MEA Atopic Dermatitis Drug Key Players Revenue
Table 2020-2025 MEA Atopic Dermatitis Drug Key Players Market Share
Table 2020-2030 MEA Atopic Dermatitis Drug Market Size by Type
Table 2020-2030 Egypt Atopic Dermatitis Drug Market Size
Table 2020-2030 Israel Atopic Dermatitis Drug Market Size
Table 2020-2030 South Africa Atopic Dermatitis Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Atopic Dermatitis Drug Market Size
Table 2020-2030 Turkey Atopic Dermatitis Drug Market Size
Table 2020-2025 Global Atopic Dermatitis Drug Market Size by Region
Table 2020-2025 Global Atopic Dermatitis Drug Market Size Share by Region
Table 2020-2025 Global Atopic Dermatitis Drug Market Size by Application
Table 2020-2025 Global Atopic Dermatitis Drug Market Share by Application
Table 2020-2025 Global Atopic Dermatitis Drug Key Vendors Revenue
Figure 2020-2025 Global Atopic Dermatitis Drug Market Size and Growth Rate
Table 2020-2025 Global Atopic Dermatitis Drug Key Vendors Market Share
Table 2020-2025 Global Atopic Dermatitis Drug Market Size by Type
Table 2020-2025 Global Atopic Dermatitis Drug Market Share by Type
Table 2025-2030 Global Atopic Dermatitis Drug Market Size by Region
Table 2025-2030 Global Atopic Dermatitis Drug Market Size Share by Region
Table 2025-2030 Global Atopic Dermatitis Drug Market Size by Application
Table 2025-2030 Global Atopic Dermatitis Drug Market Share by Application
Table 2025-2030 Global Atopic Dermatitis Drug Key Vendors Revenue
Figure 2025-2030 Global Atopic Dermatitis Drug Market Size and Growth Rate
Table 2025-2030 Global Atopic Dermatitis Drug Key Vendors Market Share
Table 2025-2030 Global Atopic Dermatitis Drug Market Size by Type
Table 2025-2030 Atopic Dermatitis Drug Global Market Share by Type

Companies Mentioned

  • Sanofi
  • Pfizer
  • AstraZeneca
  • Novartis
  • Eli Lilly
  • AbbVie
  • Regeneron Pharmaceuticals
  • LEO Pharma
  • GALDERMA LABORATORIES
  • Otsuka Pharmaceutical
  • Incyte Corporation

Related Topics

Related Reports

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Atopic Dermatitis Drugs Market by Drug Class, Route Of Administration, Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast to 2030 - Product Image

Atopic Dermatitis Drugs Market by Drug Class, Route Of Administration, Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025 - Product Image

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • 1432 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.